Locating the right evidence for merger decisions
Candace Imison asks whether potentially merging trusts’ evidence will meet the Competition and Cooperation panel’s exacting review standards, and what the challenge means for the 20 currently unviable trusts in the FT status pipeline.
Subscriber only content
You must be a paid subscriber to Health Service Journal magazine to read this article and receive complete, unrestricted access to hsj.co.uk
HSJ Subscribers:
If you are a Health Service Journal subscriber please sign in with your email address and click submit:
Not a HSJ subscriber?
Choose one of these options:
Subscribe today for immediate access to hsj.co.uk and Health Service Journal magazine
Find out more about the benefits of a subscription to HSJ by clicking below, or view a sample issue here
